HK Stock Market Move | JINHAI MED TECH (02225) surged over 11% in early trading after being included in the Hang Seng Composite Index, and it is expected to enter the Hong Kong Stock Connect subsequently.

JINHAI MED TECH (02225) surged over 11% in the early session, and as of the time of writing, was up 10.86%, trading at HKD 5.36, with a transaction volume of HKD 11.2177 million. On the news front, the Hang Seng Index Company released the results of its quarterly review, with changes to the Hang Seng Composite Index set to be implemented after the market closes on September 4 (Friday) and to take effect from September 7 (Monday). Among these changes, JINHAI MED TECH has been included in the Hang Seng Composite Index and may subsequently be incorporated into the Hong Kong Stock Connect, as it meets a series of criteria including market capitalization and liquidity. On August 3, JINHAI MED TECH announced the appointment of Mr. Ma Chengdong as the Group's Chief Marketing Officer, effective from August 3, 2026, for an initial term of one year. According to the announcement, Mr. Ma will be primarily responsible for the Group's product marketing strategies, market access, academic promotion, and sales and channel operations, as well as overseeing the commercialization of the Group's medical devices and equipment products.